LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma

Notwithstanding the researches on biomarkers and targeted therapies in renal cell carcinomas (RCC) have made progress in the last decades, the application of the biomarkers and targeted therapy agents for RCC in clinic are restricted because of their limitation or side effects. Liver X receptors (LX...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, KeShan, Xu, TianBo, Ruan, HaiLong, Xiao, HaiBing, Liu, Jingchong, Song, ZhengShuai, Cao, Qi, Bao, Lin, Liu, Di, Wang, Cheng, Cheng, Gong, Liang, HuaGeng, Chen, ZhaoHui, Yang, HongMei, Chen, Ke, Zhang, XiaoPing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377709/
https://www.ncbi.nlm.nih.gov/pubmed/30770793
http://dx.doi.org/10.1038/s41419-019-1345-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377709/
https://www.ncbi.nlm.nih.gov/pubmed/30770793
http://dx.doi.org/10.1038/s41419-019-1345-3

Ejemplares similares